| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.04e-03 | 188 | 9 | 2 | GO:0005201 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.13e-05 | 109 | 9 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.24e-03 | 656 | 9 | 3 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.26e-03 | 658 | 9 | 3 | GO:0030312 | |
| Domain | VWFD | 1.92e-05 | 16 | 8 | 2 | PS51233 | |
| Domain | VWD | 1.92e-05 | 16 | 8 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.92e-05 | 16 | 8 | 2 | IPR001846 | |
| Domain | VWD | 1.92e-05 | 16 | 8 | 2 | PF00094 | |
| Domain | EGF | 1.23e-03 | 126 | 8 | 2 | PF00008 | |
| Domain | EGF | 4.20e-03 | 235 | 8 | 2 | SM00181 | |
| Domain | EGF_3 | 4.20e-03 | 235 | 8 | 2 | PS50026 | |
| Domain | EGF-like_dom | 4.70e-03 | 249 | 8 | 2 | IPR000742 | |
| Domain | EGF_1 | 4.92e-03 | 255 | 8 | 2 | PS00022 | |
| Domain | EGF-like_CS | 5.15e-03 | 261 | 8 | 2 | IPR013032 | |
| Domain | EGF_2 | 5.31e-03 | 265 | 8 | 2 | PS01186 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 4.19e-08 | 16 | 7 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 5.08e-08 | 17 | 7 | 3 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.93e-08 | 21 | 7 | 3 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.32e-07 | 23 | 7 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.94e-07 | 26 | 7 | 3 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.53e-06 | 60 | 7 | 3 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.80e-06 | 62 | 7 | 3 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.71e-06 | 68 | 7 | 3 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.54e-05 | 109 | 7 | 3 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.63e-05 | 111 | 7 | 3 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 3.26e-05 | 140 | 7 | 3 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.47e-05 | 143 | 7 | 3 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.83e-04 | 250 | 7 | 3 | M27554 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 1.17e-03 | 1128 | 7 | 4 | M1036 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 2.47e-02 | 1389 | 7 | 3 | MM15307 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 9.76e-09 | 18 | 9 | 3 | 18834073 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 14690056 | ||
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 23544943 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 35879412 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 27483328 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 24204560 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 23053434 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 1.79e-07 | 3 | 9 | 2 | 17592322 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 24939955 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 27230679 | ||
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 30236127 | ||
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 3.57e-07 | 4 | 9 | 2 | 39024979 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 5.95e-07 | 5 | 9 | 2 | 11062147 | |
| Pubmed | 8.92e-07 | 6 | 9 | 2 | 19110483 | ||
| Pubmed | 4.86e-05 | 41 | 9 | 2 | 16740002 | ||
| Pubmed | 6.12e-05 | 46 | 9 | 2 | 19190083 | ||
| Pubmed | 1.36e-04 | 417 | 9 | 3 | 19199708 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.29e-04 | 497 | 9 | 3 | 36774506 | |
| Interaction | PABIR3 interactions | 6.37e-06 | 9 | 9 | 2 | int:PABIR3 | |
| Interaction | SPNS3 interactions | 3.71e-05 | 21 | 9 | 2 | int:SPNS3 | |
| Interaction | HBM interactions | 6.19e-05 | 27 | 9 | 2 | int:HBM | |
| Interaction | CLCN2 interactions | 1.59e-04 | 43 | 9 | 2 | int:CLCN2 | |
| Interaction | DDX31 interactions | 1.63e-04 | 257 | 9 | 3 | int:DDX31 | |
| Interaction | USB1 interactions | 2.23e-04 | 51 | 9 | 2 | int:USB1 | |
| Interaction | FRMD1 interactions | 2.32e-04 | 52 | 9 | 2 | int:FRMD1 | |
| Interaction | ITLN2 interactions | 2.99e-04 | 59 | 9 | 2 | int:ITLN2 | |
| Interaction | EBF2 interactions | 2.99e-04 | 59 | 9 | 2 | int:EBF2 | |
| Interaction | LGALS1 interactions | 3.46e-04 | 332 | 9 | 3 | int:LGALS1 | |
| Interaction | ARHGAP12 interactions | 3.98e-04 | 68 | 9 | 2 | int:ARHGAP12 | |
| Interaction | ICE2 interactions | 5.10e-04 | 77 | 9 | 2 | int:ICE2 | |
| Interaction | RANBP9 interactions | 7.51e-04 | 433 | 9 | 3 | int:RANBP9 | |
| Interaction | TIMM10 interactions | 8.75e-04 | 101 | 9 | 2 | int:TIMM10 | |
| Interaction | PCK2 interactions | 9.81e-04 | 107 | 9 | 2 | int:PCK2 | |
| Interaction | GNG8 interactions | 1.34e-03 | 125 | 9 | 2 | int:GNG8 | |
| Interaction | FBXO22 interactions | 1.42e-03 | 540 | 9 | 3 | int:FBXO22 | |
| Interaction | TWF1 interactions | 2.51e-03 | 172 | 9 | 2 | int:TWF1 | |
| Interaction | KLK10 interactions | 2.74e-03 | 180 | 9 | 2 | int:KLK10 | |
| GeneFamily | CD molecules|Mucins | 2.69e-08 | 21 | 6 | 3 | 648 | |
| Coexpression | TRAVAGLINI_LUNG_GOBLET_CELL | 1.45e-05 | 148 | 9 | 3 | M41655 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.76e-05 | 158 | 9 | 3 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.19e-05 | 170 | 9 | 3 | M5880 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN | 3.55e-05 | 200 | 9 | 3 | M9588 | |
| Coexpression | DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS | 6.42e-05 | 244 | 9 | 3 | M40175 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_D | 8.12e-05 | 40 | 9 | 2 | M19164 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL | 8.53e-05 | 41 | 9 | 2 | M39158 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL | 1.20e-04 | 301 | 9 | 3 | M45708 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL | 1.96e-04 | 62 | 9 | 2 | M45790 | |
| Coexpression | NABA_MATRISOME | 2.35e-04 | 1008 | 9 | 4 | MM17056 | |
| Coexpression | BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE | 2.43e-04 | 69 | 9 | 2 | M2533 | |
| Coexpression | NABA_MATRISOME | 2.51e-04 | 1026 | 9 | 4 | M5889 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 5.05e-04 | 491 | 9 | 3 | MM455 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_1_CELL | 6.05e-04 | 109 | 9 | 2 | M45707 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR | 6.50e-04 | 113 | 9 | 2 | M39153 | |
| Coexpression | AIZARANI_LIVER_C32_MVECS_3 | 7.95e-04 | 125 | 9 | 2 | M39131 | |
| Coexpression | TRAVAGLINI_LUNG_MUCOUS_CELL | 7.95e-04 | 125 | 9 | 2 | M41656 | |
| Coexpression | KRAS.PROSTATE_UP.V1_DN | 1.01e-03 | 141 | 9 | 2 | M2901 | |
| CoexpressionAtlas | BM Top 100 - trachea | 3.09e-06 | 72 | 9 | 3 | BM Top 100 - trachea | |
| CoexpressionAtlas | BM Top 100 - bronchus | 3.64e-06 | 76 | 9 | 3 | BM Top 100 - bronchus | |
| CoexpressionAtlas | cervix, uterine | 2.76e-05 | 149 | 9 | 3 | cervix, uterine | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.53e-04 | 265 | 9 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#3_top-relative-expression-ranked_200 | 1.71e-04 | 47 | 9 | 2 | gudmap_kidney_adult_RenCorpuscGlomer_k3_200 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 2.81e-08 | 176 | 9 | 4 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-08 | 187 | 9 | 4 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.90e-08 | 191 | 9 | 4 | 30e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.90e-08 | 191 | 9 | 4 | 41d2f5278f6d5f52a5bdf4f3df70969481c00162 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-08 | 192 | 9 | 4 | f627a3f43e2340c8ba502211940171f25c7ff436 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-08 | 192 | 9 | 4 | 612be3f861bd2f71a31c57f48c8b10930c3471ea | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.15e-08 | 194 | 9 | 4 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.69e-08 | 200 | 9 | 4 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-06 | 159 | 9 | 3 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.72e-06 | 161 | 9 | 3 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.93e-06 | 164 | 9 | 3 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-06 | 170 | 9 | 3 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 171 | 9 | 3 | d2a10e94b0490120d1420b944302eb841f902c64 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.61e-06 | 173 | 9 | 3 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.61e-06 | 173 | 9 | 3 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.61e-06 | 173 | 9 | 3 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | (03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint | 4.69e-06 | 174 | 9 | 3 | ebdddb5091afcc49ab533c890f260f709880c5f9 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.03e-06 | 178 | 9 | 3 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.03e-06 | 178 | 9 | 3 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-06 | 178 | 9 | 3 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-06 | 178 | 9 | 3 | fce60ce6b662f1bdaa3b4da43800c6c22fe89533 | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.03e-06 | 178 | 9 | 3 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | Club_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.03e-06 | 178 | 9 | 3 | be64d4be23fb96a4cdd7980c58880fdfe817747f | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-06 | 178 | 9 | 3 | b19c906e067b07eadfd68934d9330b447e24c708 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-06 | 178 | 9 | 3 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.11e-06 | 179 | 9 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.11e-06 | 179 | 9 | 3 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.20e-06 | 180 | 9 | 3 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.20e-06 | 180 | 9 | 3 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.20e-06 | 180 | 9 | 3 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.20e-06 | 180 | 9 | 3 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.37e-06 | 182 | 9 | 3 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 5.46e-06 | 183 | 9 | 3 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 5.46e-06 | 183 | 9 | 3 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.55e-06 | 184 | 9 | 3 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-06 | 184 | 9 | 3 | 4b864c74e2cf7e58d6bd151f955c43d72f035d52 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-06 | 184 | 9 | 3 | 45ff845ceed5960a997545c1009012b65e377d50 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 5.55e-06 | 184 | 9 | 3 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.55e-06 | 184 | 9 | 3 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-06 | 184 | 9 | 3 | 2cc2646dee3c6001f7c10b7449c17d1935021958 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-06 | 185 | 9 | 3 | 4d0f3d86fab02c80093e62cb0c79c586c13c5412 | |
| ToppCell | (5)_Glands_duct|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.73e-06 | 186 | 9 | 3 | ad8d5010e5095508f4995e0c6c016a44e8ffb8dd | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 5.73e-06 | 186 | 9 | 3 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.73e-06 | 186 | 9 | 3 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.92e-06 | 188 | 9 | 3 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-06 | 188 | 9 | 3 | 137ed9958044fab7a13648affb469585d1c48cf6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.92e-06 | 188 | 9 | 3 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-06 | 188 | 9 | 3 | 8ffb5394f7b00ea483a5fe4df894d22fda935e5c | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-06 | 189 | 9 | 3 | ee15b4fb3a1cfda80bcf210a23f04f242594015e | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.02e-06 | 189 | 9 | 3 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-06 | 189 | 9 | 3 | dc6f6fae84347d145bea71b49eaeeb3028e9c4ae | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.11e-06 | 190 | 9 | 3 | 576c45a30a4808b47433bc6c2c41396135556c40 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 6.11e-06 | 190 | 9 | 3 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.11e-06 | 190 | 9 | 3 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.11e-06 | 190 | 9 | 3 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.21e-06 | 191 | 9 | 3 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.21e-06 | 191 | 9 | 3 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.21e-06 | 191 | 9 | 3 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.21e-06 | 191 | 9 | 3 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.21e-06 | 191 | 9 | 3 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.21e-06 | 191 | 9 | 3 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 6.21e-06 | 191 | 9 | 3 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 6.21e-06 | 191 | 9 | 3 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 6.21e-06 | 191 | 9 | 3 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.21e-06 | 191 | 9 | 3 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.31e-06 | 192 | 9 | 3 | c227ab1914191e839fc39c9adc2080026d4b04fc | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 6.31e-06 | 192 | 9 | 3 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 6.31e-06 | 192 | 9 | 3 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.31e-06 | 192 | 9 | 3 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.31e-06 | 192 | 9 | 3 | f573b2d205bd4d053a548af3fe3ff9de7be0cd2b | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.41e-06 | 193 | 9 | 3 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.41e-06 | 193 | 9 | 3 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.41e-06 | 193 | 9 | 3 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.41e-06 | 193 | 9 | 3 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | facs-Trachea-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.41e-06 | 193 | 9 | 3 | ec49a83b24371579d4ad46aad91c25115aa226f9 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.51e-06 | 194 | 9 | 3 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.51e-06 | 194 | 9 | 3 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.51e-06 | 194 | 9 | 3 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 6.51e-06 | 194 | 9 | 3 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | C_06|World / shred on cell type and cluster | 6.51e-06 | 194 | 9 | 3 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-06 | 195 | 9 | 3 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-06 | 195 | 9 | 3 | fc2a1d84b3d013e5cb9e7b9cdd740e4010897d20 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-06 | 195 | 9 | 3 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.61e-06 | 195 | 9 | 3 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.61e-06 | 195 | 9 | 3 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-06 | 196 | 9 | 3 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.71e-06 | 196 | 9 | 3 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-06 | 196 | 9 | 3 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-06 | 196 | 9 | 3 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.71e-06 | 196 | 9 | 3 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.71e-06 | 196 | 9 | 3 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-06 | 196 | 9 | 3 | 60ea673ed887fe3890c5cf4ff4165384b76d7361 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.71e-06 | 196 | 9 | 3 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.71e-06 | 196 | 9 | 3 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.71e-06 | 196 | 9 | 3 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 6.71e-06 | 196 | 9 | 3 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | 15-Trachea|15 / Age, Tissue, Lineage and Cell class | 6.71e-06 | 196 | 9 | 3 | fd17403422cf95c24f6be1c2d78764bb352f7f2e | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 6.71e-06 | 196 | 9 | 3 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 6.81e-06 | 197 | 9 | 3 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.81e-06 | 197 | 9 | 3 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 5.26e-07 | 186 | 9 | 4 | 3768_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A | 6.76e-07 | 198 | 9 | 4 | 4603_UP | |
| Drug | potassium persulfate | 3.20e-05 | 22 | 9 | 2 | ctd:C009007 | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 5.00e-05 | 195 | 9 | 3 | 2875_UP | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 5.00e-05 | 195 | 9 | 3 | 6039_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 5.16e-05 | 197 | 9 | 3 | 6054_UP | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A | 5.39e-05 | 200 | 9 | 3 | 5730_UP | |
| Drug | I pN | 1.24e-04 | 43 | 9 | 2 | CID000012276 | |
| Drug | trofosfamide | 1.55e-04 | 48 | 9 | 2 | CID000065702 | |
| Drug | Zearalenone | 3.85e-04 | 389 | 9 | 3 | ctd:D015025 | |
| Drug | deoxynivalenol | 7.16e-04 | 481 | 9 | 3 | ctd:C007262 | |
| Drug | fullerene C60 | 1.80e-03 | 1498 | 9 | 4 | ctd:C069837 | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.88e-03 | 168 | 9 | 2 | 4671_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; PC3; HT_HG-U133A | 2.20e-03 | 182 | 9 | 2 | 6663_UP | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 2.20e-03 | 182 | 9 | 2 | 7376_UP | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; PC3; HT_HG-U133A | 2.20e-03 | 182 | 9 | 2 | 3699_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 2.23e-03 | 183 | 9 | 2 | 5764_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.25e-03 | 184 | 9 | 2 | 4369_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.28e-03 | 185 | 9 | 2 | 1226_UP | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.30e-03 | 186 | 9 | 2 | 6793_UP | |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 2.30e-03 | 186 | 9 | 2 | 1228_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 1218_UP | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 3677_UP | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 5116_UP | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.35e-03 | 188 | 9 | 2 | 2239_UP | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.37e-03 | 189 | 9 | 2 | 6895_UP | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 3232_UP | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 4244_UP | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 2561_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; PC3; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 6734_UP | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; HL60; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 2738_UP | |
| Drug | pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 6893_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 4186_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 4202_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 2079_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 3708_UP | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; HL60; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 2509_UP | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 4410_DN | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; HL60; HG-U133A | 2.47e-03 | 193 | 9 | 2 | 1547_UP | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 3799_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 3969_DN | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 5056_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 5752_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 3968_DN | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 3301_UP | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 2.50e-03 | 194 | 9 | 2 | 828_UP | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 4015_UP | |
| Drug | ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 1205_UP | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 3680_UP | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4634_UP | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4576_UP | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4232_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 3800_UP | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 7504_UP | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 5885_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; HL60; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 2736_UP | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4172_UP | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 6557_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 5240_UP | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; HL60; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 2425_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 1214_UP | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4647_UP | |
| Drug | SC 19220; Up 200; 10uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 7060_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4199_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4200_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3690_UP | |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 5097_UP | |
| Drug | Theobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4958_UP | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6748_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3314_UP | |
| Drug | Amrinone [60719-84-8]; Up 200; 21.4uM; HL60; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2724_UP | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4741_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3889_UP | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4206_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 1820_UP | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4607_UP | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4196_DN | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 5251_UP | |
| Disease | cholangiocarcinoma (is_marker_for) | 8.10e-07 | 64 | 9 | 3 | DOID:4947 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 3.72e-06 | 10 | 9 | 2 | DOID:10754 (is_marker_for) | |
| Disease | glioblastoma (is_implicated_in) | 2.27e-05 | 24 | 9 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.50e-04 | 61 | 9 | 2 | DOID:3587 (is_marker_for) | |
| Disease | lung adenocarcinoma (is_marker_for) | 2.91e-04 | 85 | 9 | 2 | DOID:3910 (is_marker_for) | |
| Disease | pancreatic cancer (is_marker_for) | 4.11e-04 | 101 | 9 | 2 | DOID:1793 (is_marker_for) | |
| Disease | Intellectual Disability | 7.68e-03 | 447 | 9 | 2 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ARSVHTWEPWSSSTA | 441 | A0A096LP49 | |
| STLWTTWTVPAQTTT | 4756 | Q9HC84 | |
| STWSSTAASDSWTVT | 3581 | Q8WXI7 | |
| TTWPSSFSSKGHTTW | 486 | Q99102 | |
| EKTTSTSLHVWWTPS | 121 | P23467 | |
| WTVHSQEATTSAWSP | 246 | Q9ULI3 | |
| SSPHSPWSAASSWTS | 1091 | O43497 | |
| SSASWKSSSVSPSSW | 366 | Q96JM3 | |
| STTTDWWHPTTTTTA | 1746 | Q9UGM3 |